产品中心 细胞因子

所有图片(1/3)

IL-10 Protein, Mouse

Interleukin-10,IL-10,Cytokine synthesis inhibitory factor (CSIF)

价格 ¥824.00 ( 供应商现货 : 3-5个工作日)
货号 UA040528
规格
数量
收藏 分享
加入对比

产品介绍 评论(0)

  • 产品介绍
  • 种属

    Mouse
  • 蛋白名称

    IL-10
  • 分子别名

    Interleukin-10, IL-10, Cytokine synthesis inhibitory factor (CSIF)
  • Accession

    P18893
  • 表达序列

    Ser19-Ser178

  • 表达系统

    HEK293
  • 分子量

    14-18 kDa (Reducing)

  • 纯度

    >95% by SDS-PAGE.
  • 内毒素含量

    <0.1EU/μg
  • 活性

    EC50 = 0.25-0.44 ng/ml
  • 标签

    No Tag
  • 分子标记

    Unconjugated
  • 性状

    Lyophilized Powder
  • 缓冲体系

    PBS, pH7.4

  • 溶解方法

    Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

  • 储存条件

    ·12 months from date of receipt, lyophilized powder stored at -20 to -80℃.

    ·3 months, -20 to -80℃ under sterile conditions after reconstitution.

    ·1 week, 2 to 8℃ under sterile conditions after reconstitution.

    ·Please avoid repeated freeze-thaw cycles.

  • 背景介绍

    Interleukin-10 (IL-10) is a key immunoregulatory cytokine critical for maintaining immune homeostasis and preventing pathological inflammation in mice. Produced by diverse immune cells including T cells, B cells, macrophages, dendritic cells, and innate lymphoid cells (ILCs), IL-10 exerts its pleiotropic effects primarily through the IL-10 receptor complex (IL-10R) and downstream JAK-STAT3 signaling. Mouse models have been instrumental in defining IL‑10's non‑redundant functions: global IL‑10 knockout (IL‑10^(−/−)) mice develop spontaneous, microbiota‑dependent colitis, establishing IL‑10 as a central guardian of intestinal immune homeostasis. Conversely, transgenic and conditional knockout mice have revealed cell‑type‑specific contributions of IL‑10 in regulating inflammation in the lungs, brain, and joint tissues.

    Major applications of mouse IL‑10 include: (1) inflammatory bowel disease (IBD) research, where IL‑10^(−/−) mice serve as a widely accepted model for Crohn's disease, enabling preclinical evaluation of microbiota‑based and immune‑modulating therapies; (2) cancer immunotherapy, where engineered IL‑10 expression—such as IL‑10‑mRNA nanoparticles—promotes cytotoxic T cell infiltration and synergizes with immune checkpoint blockade to achieve durable antitumor immunity; (3) autoimmune and inflammatory disease studies, including rheumatoid arthritis, multiple sclerosis, and osteoarthritis, where IL‑10 signaling limits tissue damage and suppresses pathogenic immune responses; and (4) neuroinflammation research, using IL‑10 knockout mice to elucidate microglial resolution mechanisms in the central nervous system.

  • 文献引用

    Nat Nanotechnol. 2025 Oct;20(10):1526-1538.

    Immunity. 2025 May 13;58(5):1306-1326.e7.

货号 产品名称 种属 表达系统 数量

评论(0)

  • dbfr